cells fig cell protein min expression figure incubated control assay data performed medium pbs results antibody buffer analysis infected shown culture previously added washed observed determined analyzed treated plates experiments activity serum antibodies infection compared usa purified effect concentration showed total western obtained transfected detected study samples incubation levels times measured vero expressed proteins treatment plasmid presence vector supernatant staining collected diluted temperature time significantly cultures human significant determine blot room fluorescence recombinant virus concentrations stained kit expressing invitrogen fold supernatants moi prepared pcr lines hours mg/ml supplemented cultured dilution test previous level overnight line plate fixed harvested transfection gel 
health public disease diseases research countries global surveillance information data national development infectious systems system international response control risk including medical outbreak human states world pandemic care provide community potential management important population resources approach emerging prevention access support include services efforts developing developed clinical local capacity years ebola outbreaks people process issues laboratory scientific effective cases review early challenges united emergency quality policy programs safety program work key future areas level biological medicine country major impact influenza million specific case current knowledge implementation treatment based assessment regional reporting drug epidemic africa funding activities time field technology preparedness develop organization 
cells immune cell response expression infection mice responses macrophages disease cytokines activation production inflammatory role tlr cns cytokine levels increased human inflammation studies lymphocytes innate receptor type specific shown receptors antigen system dcs immunity important function molecules mechanisms induced mhc activated found cxcl class monocytes lung t-cell development infections expressed induction neutrophils ccl including stimulation ifn tissue autoimmune chronic antibodies induce vitro antigens peripheral epithelial patients blood vivo microglia chemokines signaling effector lps addition memory ccr viral acute ifn-γ model compared demyelination mouse adaptive demonstrated results diseases observed effects astrocytes early proliferation dendritic high eae factor increase brain play reduced 
patients study group studies treatment results data significant asthma age compared clinical risk analysis higher years groups significantly levels included subjects days mortality increased test total showed found score time reported symptoms factors effect hospital severe lower day table performed rate differences patient outcomes median disease control difference level outcome methods trial high copd association severity baseline icu cohort number effects positive children period population variables criteria received months increase chronic prevalence acute observed trials scores therapy conclusion measured admission blood findings assessed exacerbations based previous serum year function low participants medical ratio range status regression statistical correlation review conducted 
virus viral viruses infection hiv replication host cells infected cell influenza antiviral human rna hcv infections studies ifitm denv genome infectious hsv hepatitis entry cellular strains treatment zikv particles hbv target dna resistance type ebov disease including proteins important activity early shown immune highly dengue humans development mutations capsid effect effects strain spread infectivity potential infect mechanisms culture high transmission effective vitro virions specific drug factors inhibitors recent envelope chikv iav recently mechanism family polymerase drugs ability inhibit cycle wnv agents inhibition resistant mutation due number primary similar genetic required interferon ebola demonstrated avian system replicate receptor multiple herpes major 
patients infection disease pneumonia treatment clinical respiratory cases acute diagnosis therapy infections lung severe fever symptoms patient children pulmonary days common risk chest blood mortality include chronic syndrome illness failure bacterial early infants cough viral including case high reported caused agents evidence due increased diagnostic present complications cap onset antibiotics findings adults years occur important weeks history normal recommended care infectious incidence considered airway oral antibiotic tests lower rate studies laboratory specific tract initial management treated ventilation months testing effective day recent suspected diseases fluid age culture signs oxygen mild commonly women ards pain features sputum pneumoniae imaging death presence 
data model models number time information network analysis results set based methods method system fig values approach study table process networks i.e parameters function e.g structure figure probability distribution size individual case prediction order section spatial algorithm large performance average test rate nodes terms shown studies proposed dynamics distance defined approaches point obtained small random systems patterns level important interactions features accuracy variables degree shows applied types considered correlation calculated step state selected database single similar provide statistical standard threshold node problem high space points matrix identify effect total search work measure dataset predicted multiple modeling paper parameter predict positive 
protein binding residues structure proteins peptide domain peptides fig site amino structural interactions pro structures figure activity sequence complex interaction residue protease domains affinity acid substrate molecular region shown form sites enzyme crystal cleavage active catalytic hydrophobic conformation acids molecules loop similar fusion conserved surface observed c-terminal bound model n-terminal conformational bind chain position table data proteases found group molecule ligand fold inhibitors helix target bond side energy regions motif hydrogen studies identified pdb core analysis formation based determined pocket predicted complexes docking high state functional function nmr small chains specificity cysteine mutant presence human cys receptor highly forms substrates 
protein proteins expression cells infection signaling ifn activation cell viral pathway response genes cellular replication host autophagy activity pathways gene apoptosis transcription role rna type irf phosphorylation nuclear immune antiviral induction dna isg degradation shown complex levels kinase stat innate induced involved figure production rig-i factor binding stress including function mrna interaction mir eif regulation factors inhibition target identified studies atg domain important caspase functions found human mechanisms cycle induce nf-κb responses mechanism tlr family study infected ifns mda death nucleus activated results pkr mediated required addition inhibit trim specific transcriptional control ubiquitin dsrna increased mitochondrial promoter mirnas expressed induces 
care patients health hospital patient medical infection staff risk control hospitals healthcare workers contact emergency participants transmission study training outbreak measures sars isolation time hand nurses information equipment procedures reported pandemic work infectious exposure covid hygiene management practice hcws facilities students room personnel knowledge personal survey ppe including number protective precautions general prevention respiratory nursing respondents guidelines public masks protection table department physicians education provide members support mask cases home family community team required practices system safety high level intervention surgical areas clinical settings symptoms spread critical important data experience provided disease recommended case face unit rooms prevent working individual 
vaccine vaccines antibodies antibody protein immune responses vaccination antigen igg recombinant response dna immunization neutralizing epitopes proteins antigens protection mice human immunity development cells specific cell gene expression delivery epitope vector production vectors immunized mabs virus challenge high protective vaccinated serum efficacy effective sera studies neutralization developed system induce adjuvant clinical induced peptide mucosal potential immunogenicity vlps target shown mab produced surface peptides based administration titers iga antigenic inactivated expressed binding animal live monoclonal dose elisa approach expressing trials humoral influenza attenuated therapeutic study safety demonstrated genes vivo single highly immunogenic cellular addition injection animals targeting administered levels subunit phage 
samples detection pcr assay dna sample positive assays sensitivity rna results test methods amplification method reaction clinical diagnostic negative primers detected detect testing specific target rt-pcr specificity tests nucleic specimens real-time primer performed probe analysis probes molecular diagnosis tested min rapid laboratory table developed acid high control standard time based sensitive viral identification culture system serum extraction kit obtained virus gene study hybridization number microarray elisa single blood products techniques multiplex laboratories pathogens antigen low signal applied conventional designed reverse screening sequences sequence antibodies targets sequencing step technology fluorescence reference diagnostics compared amplified reactions lamp collected polymerase concentration presence specimen 
influenza respiratory children study virus viruses rsv viral infection infections patients age years studies detected cases clinical tract samples symptoms illness data hrv positive disease hmpv table found human pneumonia reported acute detection lower pathogens adults severe rhinovirus infants specimens common months hbov identified seasonal year group compared nasal days pcr adenovirus hospital higher significant pandemic asthma collected bronchiolitis hospitalized season bacterial rate rates piv number population included groups similar period wheezing surveillance results including tested performed observed analysis severity parainfluenza prevalence young upper nasopharyngeal pneumoniae ili high incidence hpiv risk vaccination aged shown previous pathogen swabs syncytial significantly episodes 
rna nsp protein sequence mrna viral replication genome translation proteins synthesis gene orf rnas fig virus dna site sequences region structure transcription end sirna mrnas polymerase shown activity figure viruses expression nucleotides genomic vitro codon mhv mutant sites strand frameshifting nucleotide rdrp initiation complex cleavage template mutations products structures conserved utr structural similar sirnas mutants trna genes found cdna transcripts regions downstream presence required rnai base domain ribosomal frame recombination cells cellular function small mechanism ribosome efficiency product frameshift helicase present elements subgenomic specific replicase yeast amino plasmid dsrna secondary genomes role pseudoknot stem promoter addition observed position cap results 
species disease human transmission humans animals virus animal bats diseases infection host pathogens population wild bat populations risk hosts cases birds infected food areas zoonotic outbreaks infectious reported viruses infections found spread pathogen rabies africa water high contact poultry including wildlife domestic exposure potential studies transmitted years dengue avian fever environmental important prevalence endemic countries outbreak reservoir natural malaria emergence individuals world asia parasite e.g due control factors parasites emerging caused number europe livestock range large america recent people mosquitoes evidence south identified occur united health vector source mosquito states environment year study north common increased considered regions mammals related 
sequences genes gene sequence genome analysis genetic sequencing species table genomes human data identified figure viruses reads phylogenetic fig number selection dna amino found nucleotide genomic mutations regions diversity evolution host region acid evolutionary protein variants samples tree based study database analyses codon strains recombination mutation reference related viral sites alignment variation proteins group total single length performed multiple family similar high previously genotype sequenced additional supplementary conserved set population rna observed present selected expression including differences similarity compared allele alleles predicted identify complete usage molecular common identity significant studies sample groups snps generated cluster families coding genbank obtained functional 
social people china government economic tourism risk chinese market world public time hong urban international policy industry media crisis change kong development disaster travel growth level effects local research impact years security countries global life state management services sars study important demand political business cities factors air major information city effect price work significant increase events financial number human national year areas due period high taiwan markets make trade natural states service country result society relationship cost million food problems found general power production climate made including role risks costs future science case energy income sector terms news negative disasters 
expression cells ace cell levels activity effects human increased mice brain studies receptor role lung tissue protein gene injury liver function ang activation disease treatment effect development increase neurons system rats found growth vivo including cancer factor reduced study mouse model endothelial muscle shown potential rat normal diseases significantly induced receptors showed therapeutic stress tissues blood inflammation involved heart important plasma models mechanisms oxidative decreased demonstrated inhibition expressed neuronal signaling inflammatory damage pathway patients results vascular administration addition reported acid regulation enzyme mechanism tumor pathways fibrosis mrna response insulin compared release control vitro cardiac metabolism cellular mmp kidney glucose formation 
cats dogs disease signs clinical blood cat treatment horses feline cases diagnosis normal fip fluid common serum examination include animals increased canine therapy small abdominal present mg/kg affected body result dog occur severe hours administration time loss heart foals ferrets chronic pain weeks results days performed fiv felv liver concentrations age rabbits reported pressure acute animal weight hepatic cardiac csf large bone presence surgical renal diseases concentration urine months test veterinary commonly diarrhea left intestinal protein plasma healthy considered diagnostic surgery gastric kittens including tissue abnormalities rate secondary occurs recommended decreased obstruction volume failure response increase tube administered oral high 
membrane proteins protein cells cell fusion surface binding membranes receptor lipid entry golgi domain acid formation particles shown vesicles plasma glycoproteins found receptors fig transport cellular glycoprotein complex form envelope acids assembly role intracellular structures transmembrane interaction virions specific amino cytoplasmic sialic pathway glycosylation release studies required cleavage cholesterol domains process function budding involved virus site glycans sites signal similar host addition ceacam presence endocytosis interactions viral secretory molecules present residues bind localization attachment lectins lectin structure lipids observed endosomal microscopy important region virion type processing endosomes cytoplasm structural figure trafficking activity glycan dc-sign mechanism components expressed molecular carbohydrate small 
cells lesions disease tissue fig cell epithelial epithelium small skin present mucosa occur infection necrosis common tissues nasal cases inflammation large occurs include normal chronic affected animals lymph surface species found liver areas form mucosal result inflammatory lesion intestinal similar intestine severe reported type tract macrophages acute lymphocytes characterized nodes develop virus caused glands loss clinical tumors primary commonly edema including damage vessels secondary system hyperplasia infections occasionally rabbits diagnosis degeneration ocular rare lymphoid membrane gland alveolar retinal organs frequently sections respiratory cavity presence body formation rats diffuse syndrome neutrophils death focal dogs atrophy injury produce anterior muscle characteristic examination 
preprint cases number epidemic model transmission population time covid license data rate infected copyright medrxiv individuals holder disease author/funder case infection peer-reviewed outbreak https://doi.org infectious doi figure period days contact display granted made international perpetuity spread control estimated china reported distribution estimates measures day susceptible fig total probability parameters countries contacts infections rates biorxiv estimate models confirmed pandemic table people incidence average results cc-by-nc-nd observed wuhan deaths individual social risk peak based study reproduction rights reserved growth reuse age early allowed onset permission outbreaks due values scenario parameter travel death interval size quarantine initial daily dynamics incubation epidemiological analysis effective 
air water particles surface temperature concentration fig high size flow nanoparticles particle system time conditions process due solution rate systems method chemical shown materials low concentrations higher surfaces environment study airborne exposure area pressure filter efficiency ventilation environmental wind studies effect aerosol properties room range light volume material results based increase nps found applications lower measured large biological diameter small building indoor potential methods source carbon applied increased heat figure compared liquid field gas reported devices droplets effects organic layer device inactivation application energy number min removal bacteria thermal addition humidity treatment table velocity filtration measurements delivery sampling mass sensor 
mice infection virus day infected animals group days mouse fig lung observed groups control viral figure levels animal mhv compared study serum data tissue titers significant rats significantly inoculation lungs detected strain dpi dose weight model tissues inoculated antibody brain challenge showed results liver time previously disease shown differences blood response weeks higher experimental treated table studies p.i sections spleen clinical test performed similar treatment increased determined strains experiments replication cells samples collected rat number injection pfu pigs titer signs balb/c loss induced total lower analysis macaques experiment vivo antigen body rna survival high laboratory controls pbs severe measured difference 
calves animals diarrhea milk cattle disease pigs days infection rotavirus age intestinal calf bovine animal study herds cows fecal feed herd colostrum period production samples control infected farms diarrhoea found dairy weeks high farm clinical neonatal birth piglets feces reported treatment feeding fed bvdv coli studies table serum time number infections water small sheep maternal enteric intestine group signs increased day mortality present factors salmonella weight risk low pregnancy shedding cryptosporidium effect higher important pig prevalence observed large affected oocysts significant igg months young due results growth respiratory diet groups life immunity pathogens gastroenteritis management considered similar increase pregnant presence 
virus strains pedv strain ibv prrsv gene viruses tgev study pigs samples viral porcine sequence orf group rna isolates detected sequences protein chickens showed infection swine amino acid china type genome analysis rt-pcr piglets pcv isolated pcr table fig coronavirus reported positive chicken infected nucleotide collected birds found observed based cpv vaccine disease region coronaviruses usa respiratory results phylogenetic pdcov identified fipv field min avian shown high pig inoculated diarrhea isolate ndv primers clinical performed groups fcov identity previously present enteric infectious hev related genbank similar including obtained compared canine virulent genotype genes signs spike kit genetic fecal highly complete 
activity compounds drug compound acid drugs inhibition inhibitors antiviral effects group treatment showed effect active reported reaction derivatives activities found inhibitory synthesis plant extract concentration inhibitor cell potent table concentrations vitro effective potential inhibit chemical plants action extracts obtained properties groups enzyme mixture fig toxicity inhibited addition agents shown solution natural yield studies isolated cells values human study products high added mmol assay results tested biological synthesized cancer cytotoxicity therapeutic including ring product water development due presence exhibited acids scheme based evaluated analogues significant method combination growth medicinal compared treated molecules derivative prepared molecular series enzymes screening production vivo formation 
bacteria bacterial resistance strains pathogens infections antimicrobial isolates coli antibiotic infection aureus organisms antibiotics microbial species infl resistant results pathogen strain mrsa pneumoniae spp microorganisms methods culture isolated colonization host uenza aeruginosa susceptibility toxin agents virulence salmonella human found growth microbiota pathogenic gram-negative tuberculosis organism fungal staphylococcus rst genes studies clinical microbes fungi signifi cultures specifi tract presence type important activity including agar treatment streptococcus mic difficile toxins cation pseudomonas intestinal identifi factors gene identified study caused gut gram-positive microbiome cases bacterium system potential role defi oral molecular candida biofilm showed major escherichia microbiology identification blood vitro susceptible pylori common 
sars-cov sars mers-cov coronavirus virus respiratory infection patients human cases mers viral cov covid coronaviruses ace reported severe transmission outbreak disease spike china rbd camels syndrome infected hcov covs study case confirmed including saudi identified protein showed acute ncov humans rna middle arabia patient positive east clinical found studies hku receptor symptoms viruses camel samples potential days spread detected dpp infections bat health high contact hcov-nl animal host data epidemic hcov-oc kong hong hajj orf pilgrims illness onset bats pneumonia table rt-pcr tested similar wuhan entry early countries related tract chinese caused world evidence antibodies rate collected close isolated mild 
blood patients cancer recipients cell tumor donor transplant transplantation donors transfusion work plasma therapy treatment patient cells risk hsct platelet cmv time marrow clinical ebv tumors survival bone received stem months chemotherapy reported rejection testing form hct lymphoma platelets information study recipient gvhd present leukemia screening products antibodies submitted allogeneic graft factor red due report years breast disease data results section treated performed institution high days liver cases units receiving potential including antibody hematopoietic therapeutic lung rbc prior support based incidence organ considered day studies cancers drug positive donation median hla developed safety autologous anemia allograft provide disclose product transfusions 
